AKT1 and hepatocellular carcinoma: Zhu et al. demonstrated that a derivative of emodin, aloe-emodin, decreased the expression of PI3KR1, AKT1, and BCL2 mRNA levels in HCC through the downregulation of the PI3K-AKT pathway [77].